Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FORMA THERAPEUTICS HOLDINGS, INC.

(FMTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Forma Therapeutics : to Participate in Upcoming Investor Conferences

05/17/2021 | 07:06am EDT

Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced that company management will participate in two upcoming investor conferences:

  • The Oppenheimer Rare & Orphan Disease Summit taking place Friday, May 21, 2021. Forma’s pre-recorded presentation will be available on May 21 at 8:00 a.m. EDT.
  • The Jefferies Virtual Healthcare Conference taking place June 1-4, 2021. Forma will present on June 2 at 11 a.m. EDT.

Webcasts/audio recordings of the conference presentations will be available in the “News & Investors” section of Forma’s website at www.formatherapeutics.com.

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our R&D engine combines deep biology insight, chemistry expertise and clinical development capabilities to create drug candidates with differentiated mechanisms of action focused on indications with high unmet need. Our work has generated a broad proprietary portfolio of programs with the potential to provide profound patient benefit. For more information, please visit www.FormaTherapeutics.com or follow us on Twitter @FORMAInc and LinkedIn.


ę Business Wire 2021
All news about FORMA THERAPEUTICS HOLDINGS, INC.
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 2500 Growth In..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell Small Cap Comp..
CI
06/25FORMA THERAPEUTICS HOLDINGS, INC.(NA : FMTX) dropped from Russell 3000E Growth I..
CI
06/21FORMA THERAPEUTICS HOLDINGS, INC. : Submission of Matters to a Vote of Security ..
AQ
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
PU
06/14FORMA THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, R..
AQ
06/14Forma Therapeutics Holdings, Inc. Announces Appointment of John Bishop as Chi..
CI
06/14FORMA THERAPEUTICS : Announces Appointment of Industry Veteran John E. Bishop, P..
BU
More news
Financials (USD)
Sales 2021 8,33 M - -
Net income 2021 -147 M - -
Net cash 2021 504 M - -
P/E ratio 2021 -7,66x
Yield 2021 -
Capitalization 1 126 M 1 126 M -
EV / Sales 2021 74,7x
EV / Sales 2022 490x
Nbr of Employees 114
Free-Float 92,2%
Chart FORMA THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Forma Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORMA THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 23,79 $
Average target price 56,50 $
Spread / Average Target 137%
EPS Revisions
Managers and Directors
Frank D. Lee President, Chief Executive Officer & Director
Todd E. Shegog Chief Financial Officer & Senior Vice President
Peter Wirth Chairman
David N. Cook Chief Scientific Officer & Senior Vice President
Patrick Kelly Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
FORMA THERAPEUTICS HOLDINGS, INC.-31.83%1 126
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.46%31 265
SEAGEN INC.-18.34%25 955